Factors that are likely to affect the PD-1/PD-L1 axis and thus must be represented in animal models, include aggressive and metastatic cancer behavior, tumor heterogeneity, mutational landscape, genetic and epigenetic cross-talk, cancer molecular subtypes, immune cell responsiveness, and innate and acquired mechanisms of drug resistance. Here, PDCD1 is linked to cancer.